How monoclonal antibodies lost the fight with new COVID variants

The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options, and new COVID variants.

Related Keywords

Raymund Razonable ,Carl Dieffenbach ,Cherrelle Dacon ,Derek Lowe ,National Institutes Of Health ,Drug Administration ,Antiviral Program For Pandemics ,National Institutes ,Joshua Tan ,Antibody Biology Unit ,